![Frontiers | Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease Frontiers | Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease](https://www.frontiersin.org/files/Articles/1004473/fcvm-09-1004473-HTML/image_m/fcvm-09-1004473-g001.jpg)
Frontiers | Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease
![Aspirin for Primary Prevention of Cardiovascular Events | Journal of the American College of Cardiology Aspirin for Primary Prevention of Cardiovascular Events | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/a7ac3f13-0704-4b82-816b-320a46ef5568/fx1.jpg)
Aspirin for Primary Prevention of Cardiovascular Events | Journal of the American College of Cardiology
![Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendation Statement | AAFP Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendation Statement | AAFP](https://www.aafp.org/content/dam/brand/aafp/pubs/afp/issues/2016/1015/od1-t1.gif)
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendation Statement | AAFP
![Understanding the New 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease | Cardiologists located in Cypress, Katy, Houston, Sealy and Fulshear, TX | Memorial Katy Cardiology Associates Understanding the New 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease | Cardiologists located in Cypress, Katy, Houston, Sealy and Fulshear, TX | Memorial Katy Cardiology Associates](https://sa1s3optim.patientpop.com/assets/images/provider/photos/2500811.jpg)
Understanding the New 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease | Cardiologists located in Cypress, Katy, Houston, Sealy and Fulshear, TX | Memorial Katy Cardiology Associates
![2 The use of aspirin for primary and secondary prevention of CAD [161] | Download Scientific Diagram 2 The use of aspirin for primary and secondary prevention of CAD [161] | Download Scientific Diagram](https://www.researchgate.net/publication/348259767/figure/fig1/AS:977975415681024@1610178917739/The-use-of-aspirin-for-primary-and-secondary-prevention-of-CAD-161.png)
2 The use of aspirin for primary and secondary prevention of CAD [161] | Download Scientific Diagram
![PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d0d1a9da91bb2852125f3fe77a8eb24002b62415/6-Figure1-1.png)
PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar
![Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings | Irish Journal of Medical Science (1971 -) Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings | Irish Journal of Medical Science (1971 -)](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11845-021-02649-5/MediaObjects/11845_2021_2649_Fig1_HTML.png)
Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings | Irish Journal of Medical Science (1971 -)
![Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials - The Lancet Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials - The Lancet](https://www.thelancet.com/cms/attachment/34d0316c-933b-42e5-a2ac-b4ab008f2af4/gr1.gif)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials - The Lancet
![Aspirin Use for Primary Secondary Prevention: Critical Appraisal of What We Know and What We Don't | tctmd.com Aspirin Use for Primary Secondary Prevention: Critical Appraisal of What We Know and What We Don't | tctmd.com](https://cf-images.us-east-1.prod.boltdns.net/v1/static/5270290550001/5bbb74cb-7e33-4967-b8ae-3920861b2bfb/645f7114-e2c7-45e0-9e62-a5b254e4b1d8/1280x720/match/image.jpg)
Aspirin Use for Primary Secondary Prevention: Critical Appraisal of What We Know and What We Don't | tctmd.com
![Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/b8e58181-8c10-4d46-a114-99ddf25bf6ce/atvbaha.122.318020.fig06.jpg)